Device Trial Radar · NCT04381728
PREvention of Intrauterine Adhesion After Hysteroscopic Surgery With Novel deGradable Film
Last checked: Nov 20, 2026Latest source record: Nov 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
23
Actual
Start
Nov 18, 2019
Primary completion
Mar 15, 2021
Study completion Mar 15, 2021
Sponsor
- Lead sponsor
- WomedNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 11, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated device
- No
- Who can join
- Female only, from 40 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Intrauterine adhesions (IUA) are the major long-term complication of intrauterine procedures and are associated with pelvic pain, menstrual disorders, obstetrical complication and infertility. Womed Leaf is a medical device specifically designed for intrauterine use that prevents intra-uterine adhesions. It is a film that acts as a mechanical barrier to keep uterus walls separated during healing. It is then naturally discharged through the cervix and vagina in less than 30 days. The PREG1 clinical investigation is designed to evaluate Womed Leaf safety under clinical conditions, in women scheduled for a hysteroscopic myomectomy as well as its efficacy.
Conditions
- Intrauterine Adhesion
Interventions
Womed LeafDevice
Womed Leaf uterine film will be inserted immediately after the myomectomy, following per-operative hysterometry.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety (Adverse Events)Time frame: 30 days
- Efficacy (Rate of Patient With no IUA)Time frame: At second look hysteroscopy between 4 and 8 weeks
- Efficacy (Intrauterine Adhesion Severity According to AFS Classification)Time frame: At second look hysteroscopy between 4 and 8 weeks
1 more outcomes with a free account
Locations
6 sites in 3 countries. Site status is shown where the registry gives one.
UZ Gent
Ghent, Belgium
CHU Nîmes
Nîmes, France
CHU Bicêtre (APHP)
Paris, France
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.